Pulse Equity: The Healthcare Robots and Gix Internet Aims to Transform Critical Deliveries in Hospitals with AI-Powered Autonomous Systems
Three robots are currently deployed under a hospital tender permitting up to 30, while GIX plans further routes and additional commercial sites.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GIX Internet (GIXI) expanded its Deliverz.AI hospital robot deployment at Sheba Medical Center to additional transport workflows in October 2026. The new workflows move bone marrow specimens to the laboratory and donated blood to the blood bank. Commercial operations began in December 2025, and more than 9,000 autonomous missions were completed as of October 2026.
Average chemotherapy medication delivery time fell from approximately 40 minutes to approximately 14 minutes over 11 months. Sheba's public tender permits up to 30 robots, with 3 currently deployed. GIX plans further hospital routes and additional commercial deployments, particularly in the U.S. It has not yet commercially deployed the platform outside healthcare.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointAverage chemotherapy delivery time fell approximately 65%, from approximately 40 to approximately 14 minutes, over 11 months.
- Minor pointSheba deployment expanded in October 2026 to bone marrow specimen and donated blood transport.
- Minor pointAutonomous operations completed more than 9,000 missions across indoor and outdoor routes as of October 2026.
- Minor pointSheba's public tender permits up to 30 robots, with 3 currently deployed.
- Minor point. Forward-looking: it has not happened yet and may not happen.GIX plans further medication and specimen routes at Sheba Medical Center.
- Minor point. Forward-looking: it has not happened yet and may not happen.GIX's growth strategy includes additional commercial deployments, particularly in the U.S., and expansion into other sectors.
Negative
- Minor pointCommercial deployment in sectors beyond healthcare has not yet occurred.
Key Figures
- Chemotherapy delivery time
- approximately 40 minutes to approximately 14 minutes
- Average delivery time; first major use case
- Delivery-time reduction
- approximately 65% over 11 months
- Chemotherapy medication deliveries
- Autonomous missions
- more than 9,000
- Completed as of October 2026
- Robots deployed
- 3 currently deployed; up to 30 permitted
- Sheba public tender
Previous AI Reports
-
Announced blood and bone-marrow delivery workflows at Sheba, extending chemotherapy logistics.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The platform is designed to act as a central operations system. It assigns tasks in real time based on location, priority and availability, and manages movement from a single interface. Its capabilities include workload prediction, resource planning and route optimization, which are designed to give operators visibility and the ability to shift priorities and direct resources to urgent tasks. The platform is designed to coordinate both robots and human staff, work with robots from different vendors and integrate with a facility's existing elevators, doors, gates and operational systems. This architecture is intended to let customers expand workflows and add compatible robot vendors through a common orchestration layer. The Company offers its solution on a software and robots-as-a-service basis.
The clearest commercial example is at Sheba Medical Center,
In October 2026, the deployment expanded to additional workflows: transporting bone marrow specimens from the hematology department to the laboratory and moving donated blood from the donation center to the blood bank. These expanded workflows extend the platform's role across additional departments. The Company plans to add further medication and specimen transport routes at the hospital, although there can be no assurance that it will do so. Sheba selected the platform under a public tender that permits the deployment of up to 30 robots, of which 3 robots are currently deployed.
GIX's strategy aims to extend beyond healthcare by creating a single intelligent management layer that can coordinate robots, people and other autonomous systems across complex operational sites. Hospitals are the Company's initial commercial application. The Company believes the platform may have potential applications in manufacturing, logistics, pharmaceuticals, semiconductor facilities, aerospace and automotive operations, although it has not yet commercially deployed in these sectors.
GIX's growth strategy centers on expanding workflows within existing sites, seeking additional commercial deployments, particularly in the
Contact:
Pulse Equity
Office@Pulse-Equity.com
Paid Promotional Disclosure
This article constitutes a paid promotional communication. GIX Internet Ltd. has engaged Pulse Equity, a brand/division of MR Solutions Limited, to provide investor awareness and promotional services, including the preparation and dissemination of this article, and has paid or for such services.
GIX Internet Ltd. reviewed and approved the content of this article but does not control how, when, or to whom the information is distributed by Pulse Equity.
This article is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of GIX Internet Ltd. Investing in GIX Internet Ltd.'s securities involves significant risks, and readers are encouraged to review GIX Internet Ltd.'s filings with the
Forward-Looking Statements
This article contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws. Forward-looking statements in this article include statements regarding the potential benefits, capabilities and applications of Rail Vision's technologies; their potential role in railway safety, automation and autonomous train operations; the potential expansion of Rail Vision's relationship with Railserve and the entry into definitive agreements; and the potential conversion of existing integrations and pilot projects into larger commercial contracts. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. For a discussion of risks and uncertainties affecting Gix Internet, please refer to Gix Internet's reports filed with the Securities and Exchange Commission ("SEC"), including, but not limited to, the risks detailed in the Company's registration statement on Form 20-F (File No. 001-43362), as amended, as filed with the SEC on June 18, 2026, and in subsequent filings with the SEC. Forward-looking statements speak only as of the date they are made.
Pulse Equity Disclaimer
This article was produced by Pulse Equity, a brand / division of MR Solutions Limited (Hong Kong), and is provided for general informational and promotional purposes only. The content does not constitute investment advice, financial advice, medical advice, or a recommendation to buy, sell, or hold any securities, nor does it constitute an offer or solicitation in any jurisdiction. Pulse Equity is not a registered broker-dealer, investment adviser, securities analyst, or medical professional. The information presented is based on publicly available sources and statements believed to be reliable at the time of publication; however, Pulse Equity makes no representations or warranties as to the accuracy or completeness of the information and has not independently verified all data referenced.
This article is sponsored and compensated by the company discussed, which may create a conflict of interest.
Readers are encouraged to conduct their own independent research and consult qualified financial, legal, medical, or other professional advisers before making any investment or health-related decisions.
Forward-looking statements referenced in this article are subject to risks and uncertainties, and actual results may differ materially. Past performance is not indicative of future results.
For full disclosures, risk factors, and forward-looking statements, please visit:
https://pulse-equity.com/disclaimer/
View original content:https://www.prnewswire.com/news-releases/pulse-equity-the-healthcare-robots-and-gix-internet-aims-to-transform-critical-deliveries-in-hospitals-with-ai-powered-autonomous-systems-302914057.html
SOURCE Pulse Equity
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What new hospital delivery workflows did GIX Internet add at Sheba in October 2026?
Deliverz.AI expanded to bone marrow specimen and donated blood transport. The workflows move specimens from the hematology department to the laboratory and donated blood from the donation center to the blood bank.
How many robots can GIX Internet deploy under Sheba's tender?
Sheba's public tender permits deployment of up to 30 robots, with 3 robots currently deployed. Deliverz.AI has operated commercially at the hospital since December 2025.